Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Critical Care Medicine|February 21, 2025
Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical TrialThiago M L Almeida, Flávio G R Freitas, Rodrigo C Figueiredo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care UnitsMarcio Soares, Fernando A Bozza, Luciano C P Azevedo, et al.
Intensive Care Medicine|October 10, 2019
ICU staffing feature phenotypes and their relationship with patients' outcomes: an unsupervised machine learning analysisFernando G Zampieri, Jorge I F Salluh, Luciano C P Azevedo, et al.
JACC. Advances|December 20, 2025
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER TrialCaio A M Tavares, Luciano C P Azevedo, Patrícia O Guimarães, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2022
Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
Eclinicalmedicine|May 24, 2023
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trialÁlvaro Avezum, Haliton Alves Oliveira Junior, Precil Diego M M Neves, et al.
Pageof 8